| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.41 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |